18 Myalgic Encephalomyelitis Clinical Trials in Dallas, TX (2026)

Q: How do I join a clinical trial in Dallas?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Dallas research site will contact you.

Recruiting Myalgic Encephalomyelitis Studies in Dallas

NCT07032389Recruiting

A Polypill for Acute Coronary Syndrome

The current study aims to investigate whether combining the standard medications prescribed after acute coronary syndrome (ACS)-aspirin, P2Y12 inhibitors, and statins-into a single polypill can improv...

Dallas, TXPHASE21,000 participantsUniversity of Texas Southwestern Medical Center

View Study Details

NCT06292104Recruiting

Phenotyping of Postural Orthostatic Tachycardia Syndrome (POTS)

This is an observational study to deeply phenotype the disorder of POTS using multiple testing modalities....

Dallas, TX350 participantsUniversity of Texas Southwestern Medical Center

View Study Details

NCT06234397Recruiting

Dose Escalation and Expansion Study of BH3120 Alone or With Pembrolizuamb in Advanced or Metastatic Solid Tumors

This is a First-in-Human, Phase 1, Dose-Escalation and Dose-Expansion study of BH3120, as a single agent and in combination with pembrolizumab, to assess safety, tolerability, MTD, RP2D, PK, and effic...

Dallas, TXPHASE1245 participantsHanmi Pharmaceutical Company Limited

View Study Details

NCT03340506Recruiting

Dabrafenib and/or Trametinib Rollover Study

This study is to provide access for patients who are receiving treatment with dabrafenib and/or trametinib in a Novartis-sponsored Oncology Global Development, Global Medical Affairs or a former GSK-s...

Dallas, TXPHASE4100 participantsNovartis Pharmaceuticals

View Study Details

NCT05693701Recruiting

Multicomponent Intervention Study- Blood Donors With High Cholesterol

The purpose and objective of this study is to improve cholesterol treatment among blood donors with FH (Familial Hypercholesterolemia)....

Dallas, TXNA100 participantsUniversity of Texas Southwestern Medical Center

View Study Details

NCT07426016Recruiting

Video vs. Direct Laryngoscopy for Less Invasive Surfactant Administration

Many preterm babies born between 22-28+6 weeks' estimated gestational age (EGA) need surfactant, a medicine that helps the lungs. The goal of the study is to compare the use of video-based visualizati...

Dallas, TXNA100 participantsUniversity of Texas Southwestern Medical Center

View Study Details

NCT07287917Recruiting

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

This study will evaluate the safety, tolerability, and preliminary effectiveness of AMXT 1501 and DFMO when combined with standard treatments for advanced solid tumors. The trial includes two groups: ...

Dallas, TXPHASE192 participantsAminex Therapeutics, Inc.

View Study Details

NCT07211685Recruiting

A Study to Learn About How Well BAY 3401016 Works in Adults With Alport Syndrome

Alport syndrome (AS) is a rare genetic condition that causes kidney disease, hearing loss, and eye abnormalities that occur due to changes in specific genes (COL4A3, COL4A4, and COL4A5). These genes h...

Dallas, TXPHASE260 participantsBayer

View Study Details

NCT07157254Recruiting

A Safety and Efficacy Study of GTX-102 in Subjects With Deletion- or Nondeletion-type Angelman Syndrome (AS)

The main goal of the study is to evaluate the safety and efficacy of GTX-102 in participants with Angelman syndrome....

Dallas, TXPHASE260 participantsUltragenyx Pharmaceutical Inc

View Study Details

NCT06789445Recruiting

A Study to Investigate the Safety of OpCT-001 in Adults Who Have Primary Photoreceptor Disease (CLARICO)

Study OpCT-001-101 is a Phase 1/2a first-in-human, multisite, 2-part interventional study to evaluate the safety, tolerability, and the effect on clinical outcomes of OpCT-001 in up to approximately 5...

Dallas, TXPHASE154 participantsBlueRock Therapeutics

View Study Details

NCT06465953Recruiting

Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation

This study will enroll participants with myelodysplastic syndromes (MDS) with an Isocitrate dehydrogenase protein, 1 (IDH1) mutation, who have not received treatment with a hypomethylating agent previ...

Dallas, TXPHASE348 participantsInstitut de Recherches Internationales Servier

View Study Details

NCT07288112Recruiting

DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma

The goal of this clinical trial is to learn if DOC1021 + pIFN will be safe and will lead to tumor responses in patients with refractory melanoma. DOC1021 is a dendritic cell immunotherapy derived from...

Dallas, TXPHASE135 participantsDiakonos Oncology Corporation

View Study Details

NCT05691465Recruiting

Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells

This phase II trial studies how well lutetium Lu 177 dotatate works in treating patients with prostate cancer with neuroendocrine differentiation that has spread to other places in the body (metastati...

Dallas, TXPHASE235 participantsNational Cancer Institute (NCI)

View Study Details

NCT05665244Recruiting

Laryngeal Cryotherapy for Refractory Neurogenic Cough

This study aims to evaluate the safety and efficacy of upper aerodigestive tract cryotherapy treatment in patients with refractory neurogenic cough in a prospective pilot study with a validated patien...

Dallas, TX28 participantsUniversity of Texas Southwestern Medical Center

View Study Details

NCT03849963Recruiting

Imaging Oxidative Metabolism and Neurotransmitter Synthesis in the Human Brain

Investigators propose to develop hyperpolarized \[13C\]-labeled pyruvate as potential imaging probes to assess two essential in vivo processes in cerebral metabolism: oxidative metabolism and synthesi...

Dallas, TX28 participantsUniversity of Texas Southwestern Medical Center

View Study Details

NCT06439836Recruiting

Pembrolizumab Plus CA-4948 for the Treatment of Patients With Progressive Metastatic Urothelial Cancer Despite Prior Immunotherapy

This phase I trial tests the safety, side effects, best dose, and effectiveness of emavusertib (CA-4948) in combination with pembrolizumab in treating patients with urothelial cancer that has spread f...

Dallas, TXPHASE127 participantsNational Cancer Institute (NCI)

View Study Details

NCT07105254Recruiting

An Open-label Single Center, Proof of Concept Study Evaluating the Efficacy of Roflumilast Foam 0.3% in Pediatric Patients With Non-Segmental Vitiligo (NSV)

An open-label single center, proof of concept study evaluating the efficacy of Roflumilast foam 0.3% in pediatric subjects with Non-Segmental Vitiligo (NSV)...

Dallas, TXPHASE220 participantsDerm Texas, PLLC

View Study Details

NCT06601296Recruiting

Radiotherapy in Combination With Checkpoint Inhibition for Patients With Metastatic Kidney Cancer

To evaluate the impact of combining innate immune system activation (with IMSA101) with antigen release (through SAbR/PULSAR) on limited progressing lesions during ongoing adaptive immune system activ...

Dallas, TXPHASE215 participantsUniversity of Texas Southwestern Medical Center

View Study Details

About Myalgic Encephalomyelitis Clinical Trials in Dallas

Myalgic encephalomyelitis (ME/CFS) is a complex, chronic illness characterized by profound fatigue, post-exertional malaise, cognitive impairment, and sleep dysfunction. It affects millions worldwide and has no definitive diagnostic test or cure. Research is exploring immune, metabolic, and neurological mechanisms.

There are currently 18 myalgic encephalomyelitis clinical trials recruiting participants in Dallas, TX. These studies are seeking a combined 2,397 participants. Research is being sponsored by University of Texas Southwestern Medical Center, Hanmi Pharmaceutical Company Limited, Novartis Pharmaceuticals and 8 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Myalgic Encephalomyelitis Clinical Trials in Dallas — FAQ

Are there myalgic encephalomyelitis clinical trials in Dallas?

Yes, there are 18 myalgic encephalomyelitis clinical trials currently recruiting in Dallas, TX. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Dallas?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Dallas research site will contact you about next steps.

Are clinical trials in Dallas free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Dallas studies also compensate for your time and travel.

What myalgic encephalomyelitis treatments are being tested?

The 18 active trials in Dallas are testing new therapies including novel drugs, biologics, and treatment approaches for myalgic encephalomyelitis.

Data updated August 28, 2026 from ClinicalTrials.gov